Spotlight 05/02/18 | Global Antimicrobial Resistance Surveillance System (GLASS)

This week, the Global Antimicrobial Resistance Surveillance System (GLASS) published their report: (Early Implementation 2016-17) detailing the participation efforts and initial outcomes across the 52 countries currently enrolled. Glass was launched in October 2015 to support the global action plan on antimicrobial resistance.

Official national AMR data are collated for Acinetobacter spp., Escherichia coliKlebsiella pneumoniaeNeisseria gonorrhoeaeSalmonella spp., Shigella spp., Staphylococcus aureus, and Streptococcus pneumoniae.

From WHO: “In this first GLASS report data vary considerably in terms of completeness, so no attempt was made to compare AMR status at a regional or global level.”

However, some figures from the report are truly staggering: AMR rates were recorded as high as 82% for bloodstream infections in some reporting countries; resistance to penicillin was found to be as high as 51%.

“As GLASS and country participation evolves, the data reported will help understand surveillance capacities and mechanisms of reporting across countries in all regions, and will inform further GLASS development.”

That said, just the process of GLASS helping the standardization of AMR data collection has already yielded some important benefits. “The Republic of Korea completely revised its national surveillance system to align with the GLASS methodology, providing data of very high quality and completeness”. Strengthened surveillance capacity and/or improved data collation has also been noted for Tunisia, Kenya, Cambodia and Afghanistan. The full report can be found here.